vaccine

Dr. Anthony Fauci, chief medical advisor for the Trump administration’s coronavirus task force, said Tuesday that he is “cautiously optimistic” that a vaccine for the coronavirus will be available to the American public by the end of the year or early 2021. “The hallmark of all really defining responses that we have to virus diseases, …

British drugmaker AstraZeneca has doubled manufacturing capacity for its potential coronavirus vaccine to 2 billion doses in a handful of deals involving Microsoft billionaire Bill Gates that guarantee early supply to lower-income countries. The deals with epidemic response group CEPI and vaccine alliance GAVI are backed by the World Health Organization and aim to quell …

Swiss drugmaker Novartis will start producing a genetic coronavirus vaccine this month under a deal with Massachusetts researchers. AveXis, Novartis’s gene-therapy arm, agreed to manufacture the vaccine being developed by Massachusetts Eye and Ear and Massachusetts General Hospital. Production will start in time for clinical trials that are scheduled to begin in the second half …

The chief executive of AstraZeneca, which is developing a leading coronavirus vaccine with Oxford University, said it is too early to deliberately expose trial participants to the pathogen, but it may become an option if ongoing tests hit a snag. The British drugmaker last week started phase 2 and 3 trials of the vaccine, looking …

The feds have ordered 300 million doses of a potential coronavirus vaccine from British drugmaker AstraZeneca, officials said Thursday. The company will get up to $1.2 billion from the US Department of Health and Human Services to speed the development and production of the vaccine with the goal of delivering the first doses as early …

US stocks slid Tuesday as investors reined in their optimism about a promising coronavirus vaccine. The Dow Jones industrial average dipped as much as 135.71 points, or 0.5 percent, to 24,461.66 in early trading to give back some its 900-point Monday rally. Hardware store chain Home Depot led the blue-chip index lower with its shares …

Moderna is selling $1.3 billion in stock to help fund its promising new coronavirus vaccine. The biotech firm announced plans to sell 17.6 million shares priced at $76 apiece in a public offering that’s expected to close around Thursday. Net proceeds from the offering will cover costs related to the manufacturing of Moderna’s COVID-19 vaccine …

American biotech firm Moderna announced Monday that its phase-one human trial for a coronavirus vaccine produced COVID-19 antibodies in every one of its participants. Two vaccine doses of 25 micrograms showed that, by day 43 of the trial, humans developed antibody levels consistent with those who have recovered from coronavirus, the company said. Participants who …

Eight prospective coronavirus vaccines have already started human trials, as the White House continues “Operation Warp Speed” with the goal of making 300 million vaccine doses available to Americans by the start of 2021. Researchers at Oxford University and drugmakers Pfizer and Moderna are among those already conducting human trials of potential vaccines, as part …

US stocks surged Monday on hopes for a coronavirus vaccine that could allow the global economy to emerge from its pandemic-induced coma. The Dow Jones industrial average jumped as much as 701.31 points, or 2.9 percent, to 24,386.73 at the open after biotech firm Moderna reported promising results from a small human trial of its …